Literature DB >> 23269809

Unraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutinin.

Mengran Qian1, Hongxing Hu, Teng Zuo, Guiqin Wang, Linqi Zhang, Paul Zhou.   

Abstract

The rapid spread of highly pathogenic avian influenza (HPAI) H5N1 virus underscores the importance of effective antiviral treatment. Previously, we developed human monoclonal antibodies 65C6 and 100F4 that neutralize almost all (sub)clades of HPAI H5N1. The conserved 65C6 epitope was mapped to the globular head of HA. However, neither the 100F4 epitope nor the neutralization mechanism by these antibodies was known. In this study, we determined the 100F4 epitope and unraveled a neutralization mechanism by antibodies 65C6 and 100F4.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23269809      PMCID: PMC3592130          DOI: 10.1128/JVI.01292-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses.

Authors:  Hsueh-Ling Janice Oh; Sara Akerström; Shuo Shen; Sándor Bereczky; Helen Karlberg; Jonas Klingström; Sunil K Lal; Ali Mirazimi; Yee-Joo Tan
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

2.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

3.  Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.

Authors:  Davide Corti; Amorsolo L Suguitan; Debora Pinna; Chiara Silacci; Blanca M Fernandez-Rodriguez; Fabrizia Vanzetta; Celia Santos; Catherine J Luke; Fernando J Torres-Velez; Nigel J Temperton; Robin A Weiss; Federica Sallusto; Kanta Subbarao; Antonio Lanzavecchia
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

4.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

5.  Comprehensive analysis of pathogen-specific antibody response in vivo based on an antigen library displayed on surface of yeast.

Authors:  Teng Zuo; Xuanling Shi; Zhonghua Liu; Linlin Guo; Qing Zhao; Tianxia Guan; Xianming Pan; Na Jia; Wuchun Cao; Boping Zhou; Mark Goldin; Linqi Zhang
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

6.  A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.

Authors:  Hongxing Hu; Jarrod Voss; Guoliang Zhang; Philippi Buchy; Teng Zuo; Lulan Wang; Feng Wang; Fan Zhou; Guiqing Wang; Cheguo Tsai; Lesley Calder; Steve J Gamblin; Linqi Zhang; Vincent Deubel; Boping Zhou; John J Skehel; Paul Zhou
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

7.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

8.  Subtype- and antigenic site-specific differences in biophysical influences on evolution of influenza virus hemagglutinin.

Authors:  Stephen J Stray; Lindsey B Pittman
Journal:  Virol J       Date:  2012-05-08       Impact factor: 4.099

9.  Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Authors:  Mark Throsby; Edward van den Brink; Mandy Jongeneelen; Leo L M Poon; Philippe Alard; Lisette Cornelissen; Arjen Bakker; Freek Cox; Els van Deventer; Yi Guan; Jindrich Cinatl; Jan ter Meulen; Ignace Lasters; Rita Carsetti; Malik Peiris; John de Kruif; Jaap Goudsmit
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240

10.  Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.

Authors:  Surender Khurana; Amorsolo L Suguitan; Yonaira Rivera; Cameron P Simmons; Antonio Lanzavecchia; Federica Sallusto; Jody Manischewitz; Lisa R King; Kanta Subbarao; Hana Golding
Journal:  PLoS Med       Date:  2009-04-21       Impact factor: 11.069

View more
  15 in total

1.  Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry.

Authors:  Zhiqiang Ku; Xiaohua Ye; Jinping Shi; Xiaoli Wang; Qingwei Liu; Zhong Huang
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

2.  Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir.

Authors:  Huanhuan Ren; Guiqin Wang; Shuangshuang Wang; Honglin Chen; Zhiwei Chen; Hongxing Hu; Genhong Cheng; Paul Zhou
Journal:  MAbs       Date:  2016-05-11       Impact factor: 5.857

Review 3.  Influenza virus antigenicity and broadly neutralizing epitopes.

Authors:  Gillian M Air
Journal:  Curr Opin Virol       Date:  2015-04-04       Impact factor: 7.090

4.  Structural and functional definition of a vulnerable site on the hemagglutinin of highly pathogenic avian influenza A virus H5N1.

Authors:  Pengfei Wang; Yanan Zuo; Jianfeng Sun; Teng Zuo; Senyan Zhang; Shichun Guo; Xuanling Shi; Mifang Liang; Paul Zhou; Linqi Zhang; Xinquan Wang
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

5.  Divergent Requirement of Fc-Fcγ Receptor Interactions for In Vivo Protection against Influenza Viruses by Two Pan-H5 Hemagglutinin Antibodies.

Authors:  Shuangshuang Wang; Huanhuan Ren; Wenbo Jiang; Honglin Chen; Hongxing Hu; Zhiwei Chen; Paul Zhou
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

6.  A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin.

Authors:  Xueyong Zhu; Yong-Hui Guo; Tao Jiang; Ya-Di Wang; Kwok-Hung Chan; Xiao-Feng Li; Wenli Yu; Ryan McBride; James C Paulson; Kwok-Yung Yuen; Cheng-Feng Qin; Xiao-Yan Che; Ian A Wilson
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

7.  The interaction of influenza H5N1 viral hemagglutinin with sialic acid receptors leads to the activation of human γδ T cells.

Authors:  Yanlai Lu; Zhen Li; Chi Ma; Hao Wang; Jing Zheng; Lianxian Cui; Wei He
Journal:  Cell Mol Immunol       Date:  2013-08-05       Impact factor: 11.530

8.  Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody.

Authors:  Xiaoli Xiong; Davide Corti; Junfeng Liu; Debora Pinna; Mathilde Foglierini; Lesley J Calder; Stephen R Martin; Yi Pu Lin; Philip A Walker; Patrick J Collins; Isabella Monne; Amorsolo L Suguitan; Celia Santos; Nigel J Temperton; Kanta Subbarao; Antonio Lanzavecchia; Steven J Gamblin; John J Skehel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

9.  Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013.

Authors:  Marc P Girard; John S Tam; Yuri Pervikov; Jacqueline M Katz
Journal:  Vaccine       Date:  2013-06-27       Impact factor: 3.641

Review 10.  B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.

Authors:  Jenna J Guthmiller; Henry A Utset; Patrick C Wilson
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.